Satraplatin (formerly JM-216; BMS-182751; JM216; BMS182751) is a DNA alkylating agent and the first oral platinum analog with antitumor activity.

GSK3117391, formerly known as GSK3117391A, is a potent HDAC inhibitor for treating chronic inflammatory disorders.

KCC 07 is an MBD2 (Methyl-CpG-binding domain protein 2) inhibitor that prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1)/p53 signaling.

Tretazicar (CB-1954; CB1954), a dinitrobenzamide analog and prodrug, is a potent and highly selective DNA alkylating agent that generates highly cytotoxic interstrand crosslinks in DNA.

Altretamine (also known as Hexamethylmelamine, NSC13875, ENT50852, WR-95704) is an alkylating anticancer drug which also acts as a chemosterilant for male houseflies and other insects.

Palifosfamide (also known as Isophosphoramide mustard; IPM; ZIO201), a synthetic mustard compound and the active metabolite of ifosfamide, is a novel DNA alkylator with antitumor activity.

Busulfan (Myleran; Busulfex IV) is a potent DNA alkylating agent with selective immunosuppressive effect on bone marrow.

Lomustine (also known as CCNU) is a nitrosourea anticancer drug that belongs to the class of DNA alkylating agents.

Treosulfan (NSC 39069; Treosulphan) is a novel and potent DNA alkylating agent with activity in ovarian cancer and other solid tumor types.

Pipobroman is a novel and potent anti-cancer drug.